We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Protein Hyperactive Cysteine Sites Identified by New Quantitative Reactivity Technique

By LabMedica International staff writers
Posted on 14 Dec 2010
Print article
A publication described a new method for determining active regions on enzymes and other proteins by using specific probes in a fashion that discriminated between high and low affinity amino acid sites.

Investigators at the Scripps Research Institute (La Jolla, CA, USA) initially used the new technology to study the reactivity of cysteine residues in enzymes. Cysteine is one of the most reactive of the amino acids and is often critically involved in determining the three-dimensional shape of protein molecules.

Two types of cysteine-specific probes were used. One probe bound to cysteine with high affinity while the other was less avid. This meant that by strictly controlling the concentration of the probe, they could determine whether it was binding to a particularly active or inactive cysteine site.

The investigators reported in the November 17, 2010, online edition of the journal Nature that they tested the technique on proteins found within a human breast cancer-cell line. They were able to identify and locate more than 800 cysteine sites on 522 proteins. For more than 90% percent of these cysteine sites the low and high concentration probes showed correspondingly low and high levels of labeling, indicating that the cysteine residues had ordinary reactivity. The other 10% of cysteine sites demonstrated a constant level of labeling for both low and high concentration probes, indicating that they were hyperreactive.

"What we have needed is a more efficient method to find and quantitatively analyze reactive sites,” said senior author Dr. Benjamin F. Cravatt, professor of chemical biology and physiology at the Scripps Institute, "not just for one protein in a purified sample but for a large set of proteins in their natural setting, such as within a whole cell or tissue.”

"It lets us find functional sites on proteins more efficiently than before, and that is going to be helpful not only for characterizing unknown proteins, but also for finding new sites of importance on already-characterized proteins. This is a relatively precise and straightforward method for screening designed proteins for functional properties,” said Dr. Cravatt. "It could be very useful for creating new enzyme catalysts for basic research and industrial applications.”

Related Links:

Scripps Research Institute


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
ACTH Assay
ACTH ELISA
New
Immunofluorescence Analyzer
MPQuanti

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.